Cell- and peptide-based immunotherapeutic approaches for glioma
- 1 May 2008
- journal article
- review article
- Published by Elsevier in Trends in Molecular Medicine
- Vol. 14 (5) , 228-235
- https://doi.org/10.1016/j.molmed.2008.03.003
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- Epidermal Growth Factor Receptor–Mediated Signal Transduction in the Development and Therapy of GliomasClinical Cancer Research, 2006
- Amplification of KIT, PDGFRA, VEGFR2, and EGFR in GliomasMolecular Cancer Research, 2006
- A Model of Human Tumor Dormancy: An Angiogenic Switch From the Nonangiogenic PhenotypeJNCI Journal of the National Cancer Institute, 2006
- Immunologic Evaluation of Personalized Peptide Vaccination for Patients with Advanced Malignant GliomaClinical Cancer Research, 2005
- Clinical Evaluation of Dendritic Cell Vaccination for Patients with Recurrent Glioma: Results of a Clinical Phase I/II TrialClinical Cancer Research, 2005
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- Negative Regulation of PKB/Akt-Dependent Cell Survival by the Tumor Suppressor PTENCell, 1998
- Vitiligo-like lesions following immunotherapy with IFNα and IL-2 in melanoma patientsEuropean Journal Of Cancer, 1994
- A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human MelanomaScience, 1991
- Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial originNature, 1985